Author
Listed:
- Jinxin Li
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Honghui Wu
(Zhejiang University
Zhejiang University
Jinhua Institute of Zhejiang University)
- Zebin Yu
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Qiwei Wang
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Xin Zeng
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Wenchang Qian
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Siqi Lu
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Lingli Jiang
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Jingyi Li
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Meng Zhu
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Yingli Han
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
- Jianqing Gao
(Zhejiang University
Zhejiang University
Jinhua Institute of Zhejiang University
Zhejiang University School of Medicine)
- Pengxu Qian
(Zhejiang University School of Medicine
Zhejiang University
Zhejiang University & Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy)
Abstract
Leukemia is a kind of hematological malignancy originating from bone marrow, which provides essential signals for initiation, progression, and recurrence of leukemia. However, how to specifically deliver drugs to the bone marrow remains elusive. Here, we develop biomimetic vesicles by infusing hematopoietic stem and progenitor cell (HSPC) membrane with liposomes (HSPC liposomes), which migrate to the bone marrow of leukemic mice via hyaluronic acid-CD44 axis. Moreover, the biomimetic vesicles exhibit superior binding affinity to leukemia cells through intercellular cell adhesion molecule-1 (ICAM-1)/integrin β2 (ITGB2) interaction. Further experiments validate that the vesicles carrying chemotherapy drug cytarabine (Ara-C@HSPC-Lipo) markedly inhibit proliferation, induce apoptosis and differentiation of leukemia cells, and decrease number of leukemia stem cells. Mechanically, RNA-seq reveals that Ara-C@HSPC-Lipo treatment induces apoptosis and differentiation and inhibits the oncogenic pathways. Finally, we verify that HSPC liposomes are safe in mice. This study provides a method for targeting bone marrow and treating leukemia.
Suggested Citation
Jinxin Li & Honghui Wu & Zebin Yu & Qiwei Wang & Xin Zeng & Wenchang Qian & Siqi Lu & Lingli Jiang & Jingyi Li & Meng Zhu & Yingli Han & Jianqing Gao & Pengxu Qian, 2024.
"Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery,"
Nature Communications, Nature, vol. 15(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50021-9
DOI: 10.1038/s41467-024-50021-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-50021-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.